Dr. Jun Zhang 张俊
Chief Physician
Department of Oncology (Chemotherapy and Radiotherapy), Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Chemotherapy and biological targeted therapy for gastrointestinal, biliary, and pancreatic tumors.
Dr. Zhang is Director of the Department of Oncology at Ruijin Hospital and a doctoral supervisor. The doctor focuses on clinical and basic research in digestive tract tumors, specifically chemotherapy and targeted therapy for gastrointestinal, biliary, and pancreatic cancers. Dr. Zhang has led national research projects, published numerous papers, and co-edited two books. Honors include the National Science and Technology Progress Award (Second Class, 2008).
Professional roles
- Vice Chair, Youth Committee of Oncology Branch, Chinese Medical Doctor Association
- Deputy Leader, Youth Group of Gastric Cancer Professional Committee, China Anti-Cancer Association (CACA)
- Executive Committee Member and Academic Secretary, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Youth Expert Committee, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Zhang Jun). Papers usually list the name as Jun Zhang or Zhang J.
Selected publications
217 papers on PubMed matched by name and affiliation; 69 as first or senior author since 2016. Most recent first- or senior-author papers:
- Bioact Mater, 2026 (senior author): The miR-212-3p/transferrin axis promotes bone regeneration by modulating iron homeostasis through Schwann cell Exosome-BMSCs communication. PubMed 42306049
- Cancer Genet, 2026 (senior author): Gut microbiota-metabolite axis in gastric cancer: Genetic causality and Ruminococcus subgroup shifts. PubMed 42202547
- Mol Cancer, 2026 (senior author): Deconstructing cancer in 3D: models, mechanisms, and personalized solutions. PubMed 42249357
- Mater Today Bio, 2026 (senior author): CGRP-empowered stem cell sheet/short nanofiber sponge via enhancing neurovascular coupling for bone regeneration. PubMed 42006713
- Int J Biol Sci, 2026 (senior author): The Role of NADPH Oxidase 4 in Neutrophil-Mediated Immune Escape in Gastric Cancer. PubMed 42157942
- Int J Biol Sci, 2026 (senior author): GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosis. PubMed 42157923
- Urol Oncol, 2026 (senior author): Somatic alterations of genitourinary malignancy of Chinese population based on tumor NGS data. PubMed 41352999
- Future Oncol, 2026 (senior author): A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19. PubMed 41332290
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion